FDA sends letter to Novo Nordisk over potential GLP-1 side effects
The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
FDA sends letter to Novo Nordisk over potential GLP-1 side effects
The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of…
B.C. limits sales of two more diabetes drugs used for weight loss
By Staff The Canadian Press Posted July 17, 2025 5:56 pm 1 min read Descrease article font size…